A Preclinical Study to Repurpose Spironolactone for Enhancing Chemotherapy Response in Bladder Cancer.
Xu D, Cao Q, Wang L, Wang J, Xu B, Attwood K, Wei L, Wu Y, Smith GJ, Katsuta E, Takabe K, Chatta G, Guru KA, Goodrich DW, Li QJ.
Xu D, et al. Among authors: smith gj.
Mol Cancer Ther. 2022 May 4;21(5):786-798. doi: 10.1158/1535-7163.MCT-21-0613.
Mol Cancer Ther. 2022.
PMID: 35247903
Free PMC article.